Sheena Dempsey to Speak at Life Sciences Regulatory Association Meeting

UK
3/8/2018 12:00:01 AM
March 8, 2018 (East Hartford, Conn.) – RWS Life Sciences Managing Director, Sheena Dempsey, will present “Understanding Language Compliance for Global Markets” to the Chicago Chapter of the Regulatory Affairs Professionals Society (RAPS), on March 21, at 5:30 PM (CDT), at AbbVie, Inc., in North Chicago. Dempsey represents the perspective of a language services provider experienced in working with regulatory teams in the pharmaceutical and medical device industries. She will educate attendees on the processes of navigating language compliance concerns to ensure successful global launches and registrations for product, and outline how to avoid the pitfalls tied to misunderstandings and improper planning and preparation. “My goal with this event is to help further educate important stakeholders in the regulatory field with information they may not usually consider,” states Dempsey. “I hope to help the audience understand this topic through a new lens.” The RAPS Chicago Chapter is coordinating the March 21 event, which will start at 5:30 PM (CDT), and includes dinner. Regulatory Affairs Certification (RAC) holders can also claim two RAC recertification credits for attending. For information and registration visit the RAPs site, or call RAPS Chicago Chapter at 301.770.2920 ext. 200. About RWS Life Sciences Under the umbrella of RWS, the world’s leading provider of global language solutions, RWS Life Sciences is the world’s second largest life sciences translation practice and provides a full suite of language services exclusively for the life sciences industry. Visit us online at www.rws.com/lifesciences. ## For information contact: Alexander Pecha, Marketing Coordinator alex.pecha@rws.com +1 860-322-6425
Get in touch
Contact us

About RWS

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.


Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.


Over the past 20 years we’ve been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.


We work with over 80% of the world’s top 100 brands, more than three-quarters of Fortune’s 20 ‘Most Admired Companies’ and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.


Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 


For further information, please visit: www.rws.com.


© 2023 All rights reserved. Information contained herein is deemed confidential and the proprietary information of RWS Group*.
*RWS Group shall mean RWS Holdings plc for and on behalf of its affiliates and subsidiaries.